Momenta Pharmaceuticals

YTD

ALL

Why Robinhood?

You can watch MNTA and buy or sell other stocks, ETFs, and their options commission-free!

About MNTA

Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection.

CEO

Craig A. Wheeler, MBA

CEOCraig A. Wheeler, MBA

Employees

—

Employees—

Headquarters

Titusville, New Jersey

HeadquartersTitusville, New Jersey

Founded

2001

Founded2001

Employees

—

Employees—

MNTA Key Statistics

Market cap

6.24B

Market cap6.24B

Price-Earnings ratio

-24.70

Price-Earnings ratio-24.70

Dividend yield

—

Dividend yield—

Average volume

2.68M

Average volume2.68M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$52.53

52 Week high$52.53

52 Week low

$12.58

52 Week low$12.58

People also own

Based on the portfolios of people who own MNTA. This list is generated using Robinhood data, and it’s not a recommendation.